Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Natur Produkt Europe is a prominent pharmaceutical group specializing in the development, manufacturing, and distribution of over-the-counter (OTC) medicines, food supplements, and medical devices. The company maintains a dominant market position in Central and Eastern Europe, particularly in Poland through its subsidiary Natur Produkt Zdrovit. Its extensive product portfolio features well-established brands such as Lacalut for oral hygiene, Skrzypovita for beauty supplements, and the Zdrovit line of vitamins. Beyond its own brands, the group operates a sophisticated manufacturing facility, Natur Produkt Pharma, which provides contract development and manufacturing services (CDMO) with a focus on effervescent tablets. In 2021, the private equity firm MidEuropa Partners acquired a majority stake in the company to support its continued growth and international expansion.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Natur Produkt Europe.